Financial Statements — PPBT
Balance Sheet
(in millions USD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Cash & Equivalents | 8.72 | 7.40 | 14.49 | 15.03 | 10.89 | 11.25 | 4.39 |
| Total Current Assets | 9.87 | 8.91 | 15.79 | 33.26 | -- | 59.28 | 8.30 |
| Total Non-current Assets* | 7.71 | 28.13 | 28.51 | 21.37 | 0.01 | 24.52 | 6.42 |
| Total Assets | 17.57 | 37.04 | 44.30 | 54.62 | 70.20 | 83.80 | 14.72 |
| Total Current Liabilities | 7.75 | 3.99 | 7.18 | 7.06 | 4.25 | 3.10 | 3.55 |
| Total Non-current Liabilities | 0.16 | 0.14 | 2.82 | 0.47 | 0.84 | 0.95 | 0.31 |
| Total Liabilities* | 7.91 | 4.13 | 10.01 | 7.52 | 5.09 | 4.05 | 3.86 |
| Retained Earnings | (171.08) | (144.69) | (137.45) | (117.57) | (95.90) | (77.52) | (49.52) |
| Total Stockholder Equity | 9.66 | 32.91 | 34.30 | 47.10 | 65.11 | 79.75 | 10.86 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Total Revenue | -- | -- | -- | -- | -- | 1.00 | 1.00 |
| Research & Development | 3.73 | 7.62 | 17.03 | 16.32 | 11.83 | 7.49 | 2.67 |
| Selling, General & Admin | -- | -- | -- | -- | 1.53 | -- | -- |
| Total Operating Expenses | 27.46 | 11.01 | -- | 22.60 | 17.93 | 13.61 | 8.16 |
| Operating Income | -- | -- | (22.27) | -- | -- | (12.61) | (7.16) |
| Tax Provision | -- | -- | -- | -- | -- | 0.22 | 0.22 |
| Net Income | -- | -- | -- | -- | 17.83 | -- | -- |
| Basic EPS | 0.03 | 4.44 | 22,133,294.00 | -- | -- | -- | -- |
| Diluted EPS | 0.03 | 4.99 | 22,133,294.00 | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | FY
2025 | FY
2024 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Operating Cash Flow | (5.66) | (14.37) | (0.37) | (12.09) | (5.58) |
| Investing Cash Flow | 0.63 | 0.51 | 13.41 | (49.59) | (0.45) |
| Financing Cash Flow | 6.33 | 6.77 | -- | 68.49 | 5.23 |
